Shiloh
Editor, Senior Moderator
Source: https://www.cidrap.umn.edu/news-perspective/2021/04/pfizer-covid-vaccine-91-effective-6-months
Pfizer COVID vaccine 91% effective for up to 6 months
Filed Under:
COVID-19
Mary Van Beusekom | News Writer | CIDRAP News
| Apr 01, 2021
The Pfizer/BioNTech COVID-19 vaccine is 91.3% effective up to 6 months after the second dose and 100% effective against severe disease as defined by the US Centers for Disease Control and Prevention (CDC), according to updated data today from the phase 3 trial.
The vaccine was also 100% effective at preventing illness among trial participants in South Africa, where the highly transmissible B1351 variant is dominant, the Pfizer news release said. No safety issues were identified among the more than 44,000 participants 16 years or older over at least 6 months' follow-up after the second shot.
In other vaccine news, the National Institutes of Health yesterday announced the launch of a phase 1 trial of the safety and effectiveness of Moderna's vaccine against B1351, which was first identified in South Africa. The study will involve about 210 volunteers 18 years and older who received the two-dose mRNA-1273 coronavirus vaccine about a year ago as part of a clinical trial, as well as unvaccinated adults aged 18 to 55, at four US research sites.
In a mistake that will delay future Johnson & Johnson US COVID-19 vaccine shipments, workers at a plant in Baltimore accidentally swapped AstraZeneca and Johnson & Johnson vaccine ingredients in late February, contaminating 15 million doses of the one-dose Johnson & Johnson vaccine, according to the New York Times.
The mistake deals a blow to Johnson & Johnson but is also an embarrassment for the company responsible for the error, Emergent Biosolutions, which the Associated Press reports has a history of US Food and Drug Administration (FDA) citations for quality-control problems. The New York Times reports the company has faced criticism for heavy lobbying for federal contracts during the pandemic, which placed "extraordinary burden" on the government's emergency stockpile.
Infections climb, especially among younger people
Meanwhile, COVID-19 cases are rising across the country, increasing 10% or more in 26 states, Washington, DC, and Puerto Rico since last week, ABC News reports. And for the first time in the pandemic, most new hospitalizations have involved younger adults, with infections among those aged 50 to 65 outpacing those older than 65, many of whom are vaccinated.
In states like Massachusetts and Michigan, new cases are rising in older children, teens, and young adults.
The United States reported 66,641 new COVID-19 infections and 1,076 deaths yesterday, for a cumulative total of 30,524,552 infections and 552,942 deaths, according to the Johns Hopkins COVID-19 tracker. As of Mar 29, 33,933 Americans were hospitalized because of coronavirus, per the CDC COVID Data Tracker.
CDC data also show that 200,496,635 doses of COVID-19 vaccine have been delivered, with 153,631,404 administered and 56,089,614 Americans fully vaccinated.
To encourage more Americans to get vaccinated, the White House will unveil the first in a series of ads in its "We Can Do This" campaign on cable and broadcast stations across the country, according to the Washington Post.
Other US news
Pfizer COVID vaccine 91% effective for up to 6 months
Filed Under:
COVID-19
Mary Van Beusekom | News Writer | CIDRAP News
| Apr 01, 2021
The Pfizer/BioNTech COVID-19 vaccine is 91.3% effective up to 6 months after the second dose and 100% effective against severe disease as defined by the US Centers for Disease Control and Prevention (CDC), according to updated data today from the phase 3 trial.
The vaccine was also 100% effective at preventing illness among trial participants in South Africa, where the highly transmissible B1351 variant is dominant, the Pfizer news release said. No safety issues were identified among the more than 44,000 participants 16 years or older over at least 6 months' follow-up after the second shot.
In other vaccine news, the National Institutes of Health yesterday announced the launch of a phase 1 trial of the safety and effectiveness of Moderna's vaccine against B1351, which was first identified in South Africa. The study will involve about 210 volunteers 18 years and older who received the two-dose mRNA-1273 coronavirus vaccine about a year ago as part of a clinical trial, as well as unvaccinated adults aged 18 to 55, at four US research sites.
In a mistake that will delay future Johnson & Johnson US COVID-19 vaccine shipments, workers at a plant in Baltimore accidentally swapped AstraZeneca and Johnson & Johnson vaccine ingredients in late February, contaminating 15 million doses of the one-dose Johnson & Johnson vaccine, according to the New York Times.
The mistake deals a blow to Johnson & Johnson but is also an embarrassment for the company responsible for the error, Emergent Biosolutions, which the Associated Press reports has a history of US Food and Drug Administration (FDA) citations for quality-control problems. The New York Times reports the company has faced criticism for heavy lobbying for federal contracts during the pandemic, which placed "extraordinary burden" on the government's emergency stockpile.
Infections climb, especially among younger people
Meanwhile, COVID-19 cases are rising across the country, increasing 10% or more in 26 states, Washington, DC, and Puerto Rico since last week, ABC News reports. And for the first time in the pandemic, most new hospitalizations have involved younger adults, with infections among those aged 50 to 65 outpacing those older than 65, many of whom are vaccinated.
In states like Massachusetts and Michigan, new cases are rising in older children, teens, and young adults.
The United States reported 66,641 new COVID-19 infections and 1,076 deaths yesterday, for a cumulative total of 30,524,552 infections and 552,942 deaths, according to the Johns Hopkins COVID-19 tracker. As of Mar 29, 33,933 Americans were hospitalized because of coronavirus, per the CDC COVID Data Tracker.
CDC data also show that 200,496,635 doses of COVID-19 vaccine have been delivered, with 153,631,404 administered and 56,089,614 Americans fully vaccinated.
To encourage more Americans to get vaccinated, the White House will unveil the first in a series of ads in its "We Can Do This" campaign on cable and broadcast stations across the country, according to the Washington Post.
Other US news
- NPR reports that the FDA approved two rapid at-home COVID-19 tests yesterday. Americans will soon be able to buy the over-the-counter Abbott BinaxNOW and Quidel Quickvue tests at drug stores. "This is a huge milestone," Michael Mina, MD, PhD, a Harvard University epidemiologist and advocate of widespread testing, told NPR. "Having an inexpensive over-the-counter test can stop the virus from spreading by detecting people who are infectious and giving them an opportunity to know their status and ideally isolate accordingly."
- The American Health Care Association and National Center for Assisted Living issued a new report showing that COVID-19 cases in US nursing homes have fallen 96%, and related deaths have dropped 91%, since Dec 20, 2020.
- Florida is underreporting its COVID-19 deaths by thousands, according to research published in March in the American Journal of Public Health, Yahoo! News Gov. Ron DeSantis has resisted lockdowns and is currently demanding that mandatory mask wearing be rolled back.